Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Medical Device Outsourcing Strategic Business Report 2023: Expanding Role of Outsourcing Partners and Rising Demand for Full-Service Providers


DUBLIN, June 7, 2023 /PRNewswire/ -- The "Medical Device Outsourcing: Global Strategic Business Report" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo

Global Medical Device Outsourcing Market to Reach $212.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Medical Device Outsourcing estimated at US$105.2 Billion in the year 2022, is projected to reach a revised size of US$212.1 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2022-2030.

Contract Manufacturing, one of the segments analyzed in the report, is projected to record a 9.9% CAGR and reach US$109.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Quality Assurance segment is readjusted to a revised 10.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $46.4 Billion, While China is Forecast to Grow at 10.4% CAGR

The Medical Device Outsourcing market in the U.S. is estimated at US$46.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$24 Billion by the year 2030 trailing a CAGR of 10.4% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.4% and 8.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.9% CAGR.

Looking Ahead to 2023

Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year.

Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What's New for 2023?

Key Topics Covered:

MARKET OVERVIEW

MARKET TRENDS & DRIVERS

FOCUS ON SELECT PLAYERS (Total 74 Featured)

For more information about this report visit https://www.researchandmarkets.com/r/9sdvyh

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets


These press releases may also interest you

at 07:35
Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, today announced positive, primary results up to Day 91 for its Phase II exploratory STARGAZE trial evaluating apraglutide in patients with steroid-refractory gastrointestinal acute...

at 07:35
dentalcorp Holdings Ltd. ("dentalcorp" or the "Company") , Canada's largest and one of North America's fastest growing networks of dental practices, today announced that it will present at the following investor conferences: 2024 Bloom Burton & Co....

at 07:30
Optimi Health Corp. (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, proudly announces its role as a Presenting Sponsor at the highly...

at 07:30
Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of...

at 07:30
Quipt Home Medical Corp. (the "Company") ?, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024...

at 07:30
Ophthalmic lens technology leader HOYA Vision Care announced the launch of iD LifeStyle® 4 with 3D Binocular Visiontm technology, the newest progressive lens in its award-winning iD LifeStyle® family, now available to order across Canada. Building...



News published on and distributed by: